Filing Details
- Accession Number:
- 0001144204-12-056461
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-10-16 18:03:48
- Reporting Period:
- 2012-10-16
- Filing Date:
- 2012-10-16
- Accepted Time:
- 2012-10-16 18:03:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1270073 | Intercept Pharmaceuticals Inc | ICPT | Pharmaceutical Preparations (2834) | 223868459 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1253170 | Srinivas Akkaraju | C/O Intercept Pharmaceuticals, Inc. 18 Desbrosses St. New York NY 10013 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2012-10-16 | 700,000 | $15.00 | 700,000 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnote |
Footnotes
- Reflects securities purchased in the Issuer's initial public offering.
- Represents shares owned directly by New Leaf Ventures II, L.P., a limited partnership of which the sole general partner is New Leaf Venture Associates II, L.P., a limited partnership of which the sole general partner is New Leaf Venture Management II, L.L.C. ("NLVM II"). Dr. Srinivas Akkaraju, in his capacity as member of NLVM II, may be deemed to beneficially own the shares to which this Form 4 relates. Dr. Akkaraju disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.